Neoadjuvant cisplatin for advanced bladder cancer. (Q33909835)

30 July 2017

1 reference

https://doi.org/10.1002/14651858.CD001426.pub2

1 reference

29 December 2023

title

Neoadjuvant cisplatin for advanced bladder cancer. (English)

1 reference

30 July 2017

1 reference

Advanced Bladder Cancer Overview Collaboration

series ordinal

1

1 reference

30 July 2017

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

1 reference

30 July 2017

CD001426

1 reference

30 July 2017

2

1 reference

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Tables of the number of patients required in clinical trials using the logrank test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Neoadjuvant chemotherapy for invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Chemotherapy for advanced bladder cancer: 'Midsummer Night's Dream' or 'Much Ado About Nothing'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Meta-analysis of the literature or of individual patient data: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Combined modality treatment with radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Neo-adjuvant (Pre-emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Systemic chemotherapy in the management of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Keynote address: a critical assessment of trials of neoadjuvant (preemptive) chemotherapy for bladder cancer: lesson for future studies of combined modality treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001426

Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001426

Should single agents be standard therapy for urothelial tract tumors?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001426

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001426

Identifiers

DOI

10.1002/14651858.CD001426

1 reference

30 July 2017

1 reference

PubMed ID

10796791